Anadolu Medical Center
| Turkey | Thailand | South Korea | |
| Diabetes mellitus treatment with stem cells | from AUD $17,407 | from AUD $21,759 | from AUD $26,836 |
Dr Erdem Turemen is a senior endocrinologist at Anadolu Medical Center with over 900 successful procedures in managing metabolic disorders.
The doctor has extensive experience in occupational medicine, having worked in this field from 2013 to 2014. Prior to that, from 2005 to 2013, the doctor served at Haseki Education and Research Hospital, contributing significantly to the medical community. Additionally, from 1987 to 2013, the doctor was involved with Haliç University, working with the Foundation for Children with Leukemia, showcasing a long-standing commitment to pediatric oncology and research.
Professor Karaöz is a pioneer in regenerative medicine who studied islet transplantation at Harvard University to find new ways to manage Type 1 Diabetes.
Dr. Suleyman Hilmi Ipekci is a professor of endocrinology at Atlas University. He treats complex hormone disorders, thyroid cancers, and pituitary diseases. He practices at Hisar Hospital Intercontinental in Istanbul. This JCI-accredited facility serves over 500,000 patients annually. Dr. Ipekci earned his medical degree and residency at Istanbul University.
Stem cell therapy for Type 1 Diabetes is available in Turkey as an intensive treatment to support pancreatic function. Mesenchymal stem cell (MSC) therapy is not a definitive cure. However, it may reduce insulin reliance by up to 70%. Leading Istanbul hospitals offer these experimental protocols under JCI-certified safety standards.
Bookimed Expert Insight: Turkey's leading regenerative medicine centres have a unique infrastructure. Clinics like Liv Hospital Ulus operate their own internal GMP-certified laboratories. This allows professors to customise cell counts and injection sites based on a patient's specific metabolic markers. This level of vertical integration is rare globally. It keeps cells fresh rather than transporting them long distances.
Patient Consensus: Patients in Turkey find the staff helpful and note that doctors are highly qualified. Some note that clinic schedules can be busy. It helps to have personal coordinators manage appointments efficiently.
Turkish clinics report success rates up to 60% in improving insulin sensitivity and lowering HbA1c levels for Type 1 Diabetes. While not a cure, regenerative therapies aim to reduce insulin dependency by up to 50%. Specialists use mesenchymal stem cells to protect remaining islet cells.
Bookimed Expert Insight: Success in Turkey often links to multidisciplinary expertise rather than just cell injections. Data shows clinics like Anadolu Medical Center combine stem cell research with established endocrinology departments. This dual approach helps manage complex metabolic needs while exploring regenerative options for Type 1 cases.
Patient Consensus: Patients in Turkey find the medical staff highly qualified and friendly during serious treatments. They suggest clarifying appointments beforehand to avoid delays and confirm specialist availability for endocrine consultations.
Turkey offers innovative regenerative medicine for Type 1 Diabetes, primarily focusing on stem cell therapy and islet transplantation. Specialised Istanbul clinics use mesenchymal and embryonic stem cells to cultivate insulin-producing cells. JCI-accredited institutions like Anadolu Medical Center provide comprehensive endocrine diagnostics, including retinal nerve fibre layer measurements.
Bookimed Expert Insight: Patient volume is a major quality indicator in Istanbul. Medipol Mega University Hospital serves over 1,000,000 patients annually. High-volume centres often house specialised research units, providing access to technologies like MR Linac and AI-supported MRI systems. Australians should check if packages include English-speaking coordinators, as seen at Anadolu Medical Center.
Patient Consensus: Patients find the medical staff at Istanbul centres very qualified and helpful. They note the clinics are professional, though appointments can occasionally be delayed due to high demand.
The best Type 1 Diabetes care in Turkey is found at JCI-accredited centres. These include Anadolu Medical Center and Medipol Mega University Hospital. These facilities offer endocrinology and evaluation programmes. Specialists use insulin pump therapy and continuous glucose monitoring to manage complex cases.
Bookimed Expert Insight: While many centres treat diabetes, Liv Hospital Ulus stands out for its regenerative medicine focus. Prof. Dr Erdal Karaoz, who trained at Harvard University, leads research into islet transplantation. Patients seeking alternatives to traditional management find protocols here. These protocols are not available at most standard clinics.
Patient Consensus: Patients find Turkish doctors highly qualified and personal coordinators helpful with logistics in Istanbul. Many advise remaining firm on self-administration of insulin during hospital stays. That way, dosing matches their established routine.
Type 1 diabetes management in Turkey includes technologies such as continuous glucose monitors and automated insulin pumps. Patients access devices like the Dexcom G6 and FreeStyle Libre alongside hybrid closed-loop systems. Specialist centres also provide regenerative approaches, including mesenchymal stem cell therapy and islet transplantation.
Bookimed Expert Insight: Turkish endocrinology experts like Dr Erdem Turemen often focus on integrated metabolic management. While many Australian patients seek standard pumps, Turkey's private sector is a hub for regenerative research. Prof. Dr Erdal Karaöz at Liv Hospital Ulus uses Harvard-based training to offer islet transplantation and stem cell therapies. These are less accessible in general practice.
Patient Consensus: Patients find insulin costs significantly lower than in Australia and appreciate the easy availability of major sensor brands. While imported pumps are reliable, many recommend bringing personal devices. This is due to rigorous local prescription processes in Turkey.
International patients can access comprehensive Type 1 diabetes (T1D) management in Turkey at JCI-accredited hospitals. Available treatments include specialist consultations, retinal nerve fibre layer (RNFL) measurements, and experimental regenerative therapies. Turkey serves thousands of international patients annually with English-speaking coordinators and specialist endocrinologists.
Bookimed Expert Insight: Many centres focus on management. However, Liv Hospital Ulus stands out for its dedicated regenerative medicine unit. Dr Erdal Karaöz established Turkey's first private GMP-standard stem cell centre. This level of infrastructure is rare. It offers patients access to cellular therapy expertise not found in standard general hospitals.
Patient Consensus: Patients find Turkish medical staff qualified and kind. Some note that appointment timing can vary in busy Istanbul centres. When travelling, patients note that basic insulin supplies and sensors are available at local pharmacies. No local prescription is needed.
Turkish medical centres offer regenerative and technological alternatives to manage Type 1 Diabetes with fewer needles. Treatments include mesenchymal stem cell therapy, islet transplantation, and automated insulin pumps. Clinics like Liv Hospital Ulus and Anadolu Medical Center specialise in these innovative approaches. They work within JCI-accredited facilities.
Bookimed Expert Insight: Patients looking for non-invasive approaches should focus on clinics with dedicated regenerative medicine centres. Liv Hospital Ulus operates a private stem cell production facility under strict manufacturing standards. Prof. Dr Erdal Karaöz and other specialists provide mesenchymal and embryonic stem cell therapies. This is made possible by the private stem cell facility. These therapies are often unavailable in standard hospitals.
Patient Consensus: Patients in Turkey find the medical staff very helpful. They also find the facilities highly qualified for serious metabolic diseases. Many emphasise that new technologies simplify management. However, staying active in dosing decisions remains vital for the best results.